Jane Street’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,200
Closed -$1.52M 10622
2022
Q3
$1.52M Sell
6,200
-19,400
-76% -$5.24M ﹤0.01% 4659
2022
Q2
$6.34M Buy
25,600
+13,900
+119% +$3.75M ﹤0.01% 2323
2022
Q1
$3.88M Buy
11,700
+5,000
+75% +$1.54M ﹤0.01% 3477
2021
Q4
$2.41M Sell
6,700
-8,800
-57% -$2.97M ﹤0.01% 4107
2021
Q3
$5.05M Sell
15,500
-7,300
-32% -$2.47M ﹤0.01% 2716
2021
Q2
$7.12M Buy
22,800
+12,200
+115% +$3.74M ﹤0.01% 2134
2021
Q1
$3.38M Sell
10,600
-30,800
-74% -$9.86M ﹤0.01% 3030
2020
Q4
$13.4M Sell
41,400
-15,900
-28% -$4.4M 0.01% 1178
2020
Q3
$15.9M Buy
57,300
+23,200
+68% +$6.68M 0.01% 905
2020
Q2
$8.24M Buy
34,100
+22,400
+191% +$4.5M 0.01% 1337
2020
Q1
$1.7M Sell
11,700
-24,000
-67% -$3.98M ﹤0.01% 2183
2019
Q4
$6.09M Buy
35,700
+27,200
+320% +$5.04M 0.01% 934
2019
Q3
$1.51M Sell
8,500
-6,200
-42% -$1.34M ﹤0.01% 2115
2019
Q2
$3.83M Sell
14,700
-10,400
-41% -$2.76M 0.01% 1271
2019
Q1
$7.17M Sell
25,100
-5,400
-18% -$1.79M 0.01% 894
2018
Q4
$9.91M Buy
30,500
+26,200
+609% +$9.1M 0.02% 581
2018
Q3
$1.93M Sell
4,300
-900
-17% -$355K ﹤0.01% 1947
2018
Q2
$2.13M Buy
+5,200
New +$1.88M 0.01% 1869
2016
Q3
Sell
-3,100
Closed -$339K 4689
2016
Q2
$339K Buy
+3,100
New +$308K ﹤0.01% 3192

Other funds holding ABMD

Jane Street's ABMD Position: Q4 2022 in Review

Jane Street sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 981 shares — an estimated $241K sold.

Jane Street first reported a position in ABMD in Q2 2014 and held it in 28 quarters. The position peaked at $9.22M in Q1 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Jane Street reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 981 Abiomed Inc shares in Q4 2022, an estimated $241K.
  • Jane Street first reported a position in Abiomed Inc in Q2 2014 and held it in 28 quarters.
  • Jane Street's Abiomed Inc position peaked at $9.22M in Q1 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.